Cargando…
Strategies to identify candidate repurposable drugs: COVID-19 treatment as a case example
Drug repurposing is an invaluable strategy to identify new uses for existing drug therapies that overcome many of the time and financial costs associated with novel drug development. The COVID-19 pandemic has driven an unprecedented surge in the development and use of bioinformatic tools to identify...
Autores principales: | Imami, Ali S., McCullumsmith, Robert E., O’Donovan, Sinead M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594646/ https://www.ncbi.nlm.nih.gov/pubmed/34785660 http://dx.doi.org/10.1038/s41398-021-01724-w |
Ejemplares similares
-
Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach
por: O’Donovan, Sinead M., et al.
Publicado: (2021) -
The role of glutamate transporters in the pathophysiology of neuropsychiatric disorders
por: O’Donovan, Sinead M., et al.
Publicado: (2017) -
Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection
por: Creeden, Justin Fortune, et al.
Publicado: (2021) -
Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS
por: O’Donovan, Sinead M, et al.
Publicado: (2020) -
Gene Enrichment Analysis of Astrocyte Subtypes in Psychiatric Disorders and Psychotropic Medication Datasets
por: Zhang, Xiaolu, et al.
Publicado: (2022)